|Bid||42.60 x 800|
|Ask||42.62 x 1800|
|Day's Range||42.55 - 43.04|
|52 Week Range||34.29 - 46.10|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||41.57|
|Forward Dividend & Yield||0.75 (1.72%)|
|Ex-Dividend Date||Apr 05, 2021|
|1y Target Est||N/A|
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of ARIA Home PT, a remote physical therapy product as part of the ARIA suite of solutions.
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, announces the publication of new research showing that clinicians estimated that 45% of their patients with chronic wounds would benefit from greater involvement in their care, and half of these clinicians believed this would enable them to spend more time with other patients.1
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces a new study showing that computer-guided technology for total hip arthroplasty (THA) – such as Smith+Nephew's RI.HIP NAVIGATION – significantly reduces the risk of revision and increases patient satisfaction when using Smith+Nephew implants.